1. Home
  2. Analysis
  3. Rabeprazole
  4. Creon

Rabeprazole and Creon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rabeprazole (rabeprazole sodium) and Creon (pancrelipase (amylase;lipase;protease)). Common drug interactions include aphasia among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Rabeprazole and Creon. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.

What is Creon?

Creon has active ingredients of pancrelipase (amylase;lipase;protease). It is often used in pancreatitis. eHealthMe is studying from 29,489 Creon users. Check the latest studies of Creon.

On Jul, 03, 2026

50 people who take Rabeprazole and Creon together, and have interactions are studied.

Rabeprazole and Creon drug interactions.

What are the common drug interactions of Rabeprazole and Creon, by gender? *:

female:

  1. Aphasia (damage to the parts of the brain that control language)
  2. Arrhythmia (irregular heartbeat)
  3. Asthma
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Cardiac disorder
  6. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  7. Cough
  8. Death
  9. Drug hypersensitivity
  10. Drug intolerance (drug sensitivity)

male:

  1. Drug ineffective
  2. Weight decreased
  3. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  4. Confusional state
  5. Dyspnoea (difficult or laboured respiration)
  6. Hallucination (an experience involving the perception of something not present)
  7. Insomnia (sleeplessness)
  8. Memory impairment
  9. Muscular weakness (muscle weakness)
  10. Panic reaction

What are the common drug interactions of Rabeprazole and Creon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Hospitalisation
  2. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)

20-29:

  1. Cystic fibrosis lung (fibrosis with cyst in the lung)
  2. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  3. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)

30-39:

  1. Abdominal pain
  2. Drug ineffective
  3. Frequent bowel movements
  4. Pus in stool
  5. Vomiting
  6. Weight decreased
  7. Addison's disease (addison's disease, a hormonal disorder disease)
  8. Chest discomfort
  9. Dyspnoea exertional (breathlessness or shortness of breath)
  10. Insomnia (sleeplessness)

40-49:

  1. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  2. Dyspnoea (difficult or laboured respiration)
  3. Muscular weakness (muscle weakness)
  4. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  5. Asthenia (weakness)
  6. Diarrhoea
  7. Gait disturbance
  8. Anxiety
  9. Arthralgia (joint pain)
  10. Chronic kidney disease

50-59:

  1. Status asthmaticus (a asthma attack not responds to regular medicines)
  2. Thrombosis (formation of a blood clot inside a blood vessel)
  3. Thyroid cancer
  4. Thyroid cancer metastatic (thyroid cancer spreads to other part)
  5. Thyroidectomy
  6. Abnormal behaviour
  7. Aggression
  8. Anxiety
  9. Confusional state
  10. Hallucination (an experience involving the perception of something not present)

60+:

  1. Chronic kidney disease
  2. Cough
  3. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  4. Anaemia (lack of blood)
  5. Aphagia (inability or refusal to swallow)
  6. Arrhythmia (irregular heartbeat)
  7. Asthenia (weakness)
  8. Asthma
  9. Blood albumin decreased
  10. Blood alkaline phosphatase increased

What are the existing conditions these people have? *

  1. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 12 people, 24.00%
  2. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 9 people, 18.00%
  3. Nausea And Vomiting: 9 people, 18.00%
  4. Colitis Microscopic (inflammation of colon with diarrhoea and abdominal cramps): 9 people, 18.00%
  5. Fungal Skin Infection: 8 people, 16.00%
  6. Cystic Fibrosis (disease of the secretary glands): 6 people, 12.00%
  7. Indigestion: 4 people, 8.00%
  8. Pancreatic Carcinoma (pancreatic cancer): 3 people, 6.00%
  9. Multiple Myeloma (cancer of the plasma cells): 3 people, 6.00%
  10. High Blood Cholesterol: 3 people, 6.00%

* Approximation only. Some reports may have incomplete information.

Do you take Rabeprazole and Creon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Rabeprazole and Creon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Rabeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Creon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Rabeprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Creon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rabeprazole sodium and pancrelipase (amylase;lipase;protease) (the active ingredients of Rabeprazole and Creon, respectively), and Rabeprazole and Creon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.